Cara Therapeutics
CARA
#9658
Rank
โ‚ฌ16.85 M
Marketcap
0,31ย โ‚ฌ
Share price
-4.96%
Change (1 day)
-72.13%
Change (1 year)

Revenue for Cara Therapeutics (CARA)

Revenue in 2024 (TTM): โ‚ฌ10.21 Million

According to Cara Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ10.42 Million. In 2023 the company made a revenue of โ‚ฌ18.96 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ39.03 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Cara Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ10.21 M-46.14%
2023 โ‚ฌ18.96 M-51.4%
2022 โ‚ฌ39.03 M91.95%
2021 โ‚ฌ20.33 M-81.49%
2020 โ‚ฌ0.10 B518.67%
2019 โ‚ฌ17.75 M50.77%
2018 โ‚ฌ11.77 M1450.68%
2017 โ‚ฌ0.75 M828.64%
2016 โ‚ฌ0.08 M-97.65%
2015 โ‚ฌ3.47 M33.15%
2014 โ‚ฌ2.61 M-69.85%
2013 โ‚ฌ8.66 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ3.36 M-67.75%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ95.17 M 813.06%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ71.44 M 585.34%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.61 M-94.08%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ52.74 B 505,920.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.13 B 797,426.37%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.10 B 951.87%๐Ÿ‡บ๐Ÿ‡ธ USA